Xilio Therapeutics (XLO) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.54
-1.05
-0.57
-0.08

Details

Expected EPS
-0.4466
Actual EPS
-1.54
Surprise EPS
-1.09
Surprise Percent
-244.83%

Description

⁨Xilio Therapeutics⁩ (⁦XLO⁩) has reported earnings of ⁦-1.54⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts